It may be my misunderstanding, but prior to today's PR, I thought they were ready to start preparing for human trials and were done with animal trials. This PR pushed back my estimated timeline from 1st Qtr 16 to 4th Qtr 16 for human trials, so it was a disappointment to me. I sold about 1MM shares, but still keeping some. It may be that others were under the same impression as me for todays sell off. I hope to get back in when closer to human trials, if it's not too late.
(0)
(0)
Propanc Biopharma, Inc. (PPCB) Stock Research Links